Chiesi Farmaceutici
Siamo un gruppo biofarmaceutico orientato alla ricerca che sviluppa e commercializza soluzioni terapeutiche innovative per la salute respiratoria, le malattie rare e le cure specialistiche.
Basic Information
- Category: Rare Diseases
- Founded: 1935
- Headquarters: Parma, Italy
- Website: chiesi.com
Documented Facts
- Email: c.travagin@chiesi.com (No linked source recorded for this statement.)
Evidence and Sources
- Chiesi Farmaceutici — Official Site (official)
- Chiesi Farmaceutici on facebook (social)
Citation Guidance
Explore Rare Diseases profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Chiesi Farmaceutici.
- Canonical profile: https://brandsource.ai/brands/chiesi-farmaceutici
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/chiesi-farmaceutici/json-ld
- Citation profile API: https://brandsource.ai/api/brands/chiesi-farmaceutici/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (81/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:07.445Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Siamo un gruppo biofarmaceutico orientato alla ricerca che sviluppa e commercializza soluzioni terapeutiche innovative per la salute respiratoria, le malattie rare e le cure specialistiche.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 1 supporting source linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.